Table 2.
Salivary testosterone and cytokines levels in the studied groups
| Group | No. of subjects | Mean | Median | Min | Max | SD | |
|---|---|---|---|---|---|---|---|
| Salivary testosterone (pg/ml) | PCOS | 31a | 40.87 | 37.18 | 23.46 | 69.91 | 13.39 |
| Control | 28 | 28.59 | 29.72 | 15.60 | 44.09 | 7.58 | |
|
TNF-α (pg/ml) |
PCOS | 31b | 21.37 | 16.51 | 12.04 | 69.72 | 14.61 |
| Control | 28 | 11.79 | 11.84 | 8.12 | 14.80 | 1.58 | |
|
IL-6 (pg/ml) |
PCOS | 31b | 11.99 | 8.97 | 5.97 | 42.72 | 8.77 |
| Control | 28 | 5.74 | 5.66 | 3.00 | 8.77 | 1.56 | |
|
IL-1β (pg/ml) |
PCOS | 31b | 177.11 | 170.32 | 67.27 | 394.53 | 54.24 |
| Control | 28 | 120.29 | 125.11 | 55.81 | 161.20 | 25.90 |
TNF-α, tumor necrosis factor α; IL-6, interleukin 6; IL-1β, interleukin 1β; N.A., not applicable
ap = 0.0007 as compared to healthy controls, Mann–Whitney U test
bp < 0.0001 as compared to healthy controls, Mann–Whitney U test